Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Gary Steven Sachs, M.D.


The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. N01MH060011 (SACHS, GARY S) Sep 30, 1996 - Sep 30, 1999
    Role: Principal Investigator
  2. N01MH080001 Sep 30, 2003
    Role: Co-Principal Investigator

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Vieta E, Sachs G, Chang D, Hellsten J, Brewer C, Peters-Strickland T, Hefting N. Two randomized, double-blind, placebo-controlled trials and one open-label, long-term trial of brexpiprazole for the acute treatment of bipolar mania. J Psychopharmacol. 2021 Aug; 35(8):971-982. PMID: 33691517.
    Citations: 1     Fields:    
  2. Ma Y, Ji J, Huang Y, Gao H, Li Z, Dong W, Zhou S, Zhu Y, Dang W, Zhou T, Yu H, Yu B, Long Y, Liu L, Sachs G, Yu X. Implementing machine learning in bipolar diagnosis in China. Transl Psychiatry. 2019 11 18; 9(1):305. PMID: 31740657.
    Citations:    Fields:    Translation:Humans
  3. Earley W, Burgess MV, Rekeda L, Dickinson R, Szatmári B, Németh G, McIntyre RS, Sachs GS, Yatham LN. Cariprazine Treatment of Bipolar Depression: A Randomized Double-Blind Placebo-Controlled Phase 3 Study. Am J Psychiatry. 2019 06 01; 176(6):439-448. PMID: 30845817.
    Citations: 14     Fields:    Translation:HumansCTClinical Trials
  4. Rosenblat JD, Simon GE, Sachs GS, Deetz I, Doederlein A, DePeralta D, Dean MM, McIntyre RS. Frequency of use and perceived helpfulness of wellness strategies for bipolar and unipolar depression. Ann Clin Psychiatry. 2018 11; 30(4):296-304. PMID: 30372507.
    Citations: 2     Fields:    Translation:Humans
  5. Rosenblat JD, Simon GE, Sachs GS, Deetz I, Doederlein A, DePeralta D, Dean MM, McIntyre RS. Factors That Impact Treatment Decisions: Results From an Online Survey of Individuals With Bipolar and Unipolar Depression. Prim Care Companion CNS Disord. 2018 Nov 01; 20(6). PMID: 30444959.
    Citations: 2     Fields:    Translation:Humans
  6. Rosenblat JD, Simon GE, Sachs GS, Deetz I, Doederlein A, DePeralta D, Dean MM, McIntyre RS. Treatment effectiveness and tolerability outcomes that are most important to individuals with bipolar and unipolar depression. J Affect Disord. 2019 01 15; 243:116-120. PMID: 30241026.
    Citations: 7     Fields:    Translation:Humans
  7. Slyepchenko A, Frey BN, Lafer B, Nierenberg AA, Sachs GS, Dias RS. Increased illness burden in women with comorbid bipolar and premenstrual dysphoric disorder: data from 1 099 women from STEP-BD study. Acta Psychiatr Scand. 2017 11; 136(5):473-482. PMID: 28846801.
    Citations: 9     Fields:    Translation:Humans
  8. Ketter TA, Sachs GS, Durgam S, Lu K, Starace A, Laszlovszky I, Németh G. The safety and tolerability of cariprazine in patients with manic or mixed episodes associated with bipolar I disorder: A 16-week open-label study. J Affect Disord. 2018 01 01; 225:350-356. PMID: 28843918.
    Citations: 7     Fields:    Translation:HumansCTClinical Trials
  9. Mahableshwarkar AR, Calabrese JR, Macek TA, Budur K, Adefuye A, Dong X, Hanson E, Sachs GS. Efficacy and safety of sublingual ramelteon as an adjunctive therapy in the maintenance treatment of bipolar I disorder in adults: A phase 3, randomized controlled trial. J Affect Disord. 2017 10 15; 221:275-282. PMID: 28662460.
    Citations: 6     Fields:    Translation:HumansCTClinical Trials
  10. Calabrese JR, Gao K, Sachs G. Diagnosing Mania in the Age of DSM-5. Am J Psychiatry. 2017 01 01; 174(1):8-10. PMID: 28040998.
    Citations:    Fields:    Translation:Humans
  11. Ma Y, Gao H, Yu X, Si T, Wang G, Fang Y, Liu Z, Sun J, Yang H, Wang X, Li J, Zhang Y, Sachs G. Bipolar diagnosis in China: Evaluating diagnostic confidence using the Bipolarity Index. J Affect Disord. 2016 Sep 15; 202:247-53. PMID: 27286368.
    Citations: 1     Fields:    Translation:Humans
  12. Daniel D, Kalali A, West M, Walling D, Hilt D, Engelhardt N, Alphs L, Loebel A, Vanover K, Atkinson S, Opler M, Sachs G, Nations K, Brady C. Data Quality Monitoring in Clinical Trials: Has It Been Worth It? An Evaluation and Prediction of the Future by All Stakeholders. Innov Clin Neurosci. 2016 Jan-Feb; 13(1-2):27-33. PMID: 27413584.
    Citations: 2     
  13. Szabo ST, Kinon BJ, Brannan SK, Krystal AK, van Gerven JM, Mahableshwarkar A, Sachs GS. Lessons Learned and Potentials for Improvement in CNS Drug Development: ISCTM Section on Designing the Right Series of Experiments. Innov Clin Neurosci. 2015 Mar-Apr; 12(3-4):11S-25S. PMID: 25977837.
    Citations: 3     
  14. Nierenberg AA, McIntyre RS, Sachs GS. Improving outcomes in patients with bipolar depression: a comprehensive review. J Clin Psychiatry. 2015 Mar; 76(3):e10. PMID: 25830453.
    Citations: 5     Fields:    Translation:Humans
  15. Aiken CB, Weisler RH, Sachs GS. The Bipolarity Index: a clinician-rated measure of diagnostic confidence. J Affect Disord. 2015 May 15; 177:59-64. PMID: 25745836.
    Citations: 5     Fields:    Translation:Humans
  16. Sachs GS, Greenberg WM, Starace A, Lu K, Ruth A, Laszlovszky I, Németh G, Durgam S. Cariprazine in the treatment of acute mania in bipolar I disorder: a double-blind, placebo-controlled, phase III trial. J Affect Disord. 2015 Mar 15; 174:296-302. PMID: 25532076.
    Citations: 24     Fields:    Translation:HumansCTClinical Trials
  17. Sachs GS, Ketter TA. Update on best practices for managing bipolar depression. J Clin Psychiatry. 2014 May; 75(5):e413-6. PMID: 24922493.
    Citations:    Fields:    Translation:Humans
  18. Loebel A, Cucchiaro J, Silva R, Kroger H, Hsu J, Sarma K, Sachs G. Lurasidone monotherapy in the treatment of bipolar I depression: a randomized, double-blind, placebo-controlled study. Am J Psychiatry. 2014 Feb; 171(2):160-8. PMID: 24170180.
    Citations: 58     Fields:    Translation:Humans
  19. Pacchiarotti I, Bond DJ, Baldessarini RJ, Nolen WA, Grunze H, Licht RW, Post RM, Berk M, Goodwin GM, Sachs GS, Tondo L, Findling RL, Youngstrom EA, Tohen M, Undurraga J, González-Pinto A, Goldberg JF, Yildiz A, Altshuler LL, Calabrese JR, Mitchell PB, Thase ME, Koukopoulos A, Colom F, Frye MA, Malhi GS, Fountoulakis KN, Vázquez G, Perlis RH, Ketter TA, Cassidy F, Akiskal H, Azorin JM, Valentí M, Mazzei DH, Lafer B, Kato T, Mazzarini L, Martínez-Aran A, Parker G, Souery D, Ozerdem A, McElroy SL, Girardi P, Bauer M, Yatham LN, Zarate CA, Nierenberg AA, Birmaher B, Kanba S, El-Mallakh RS, Serretti A, Rihmer Z, Young AH, Kotzalidis GD, MacQueen GM, Bowden CL, Ghaemi SN, Lopez-Jaramillo C, Rybakowski J, Ha K, Perugi G, Kasper S, Amsterdam JD, Hirschfeld RM, Kapczinski F, Vieta E. The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders. Am J Psychiatry. 2013 Nov; 170(11):1249-62. PMID: 24030475.
    Citations: 118     Fields:    Translation:Humans
  20. Sachs GS, Peters AT, Sylvia L, Grunze H. Polypharmacy and bipolar disorder: what's personality got to do with it? Int J Neuropsychopharmacol. 2014 Jul; 17(7):1053-61. PMID: 24067291.
    Citations: 10     Fields:    Translation:Humans
  21. Sachs GS. Unmet needs in the assessment and management of bipolar I depression. J Clin Psychiatry. 2013 Jun; 74(6):e11. PMID: 23842019.
    Citations: 1     Fields:    Translation:Humans
  22. Sylvia LG, Hay A, Ostacher MJ, Miklowitz DJ, Nierenberg AA, Thase ME, Sachs GS, Deckersbach T, Perlis RH. Association between therapeutic alliance, care satisfaction, and pharmacological adherence in bipolar disorder. J Clin Psychopharmacol. 2013 Jun; 33(3):343-50. PMID: 23609394.
    Citations: 13     Fields:    Translation:Humans
  23. Sachs GS, Vanderburg DG, Karayal ON, Kolluri S, Bachinsky M, Cavus I. Adjunctive oral ziprasidone in patients with acute mania treated with lithium or divalproex, part 1: results of a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry. 2012 Nov; 73(11):1412-9. PMID: 23218157.
    Citations: 4     Fields:    Translation:Humans
  24. Sachs GS, Vanderburg DG, Edman S, Karayal ON, Kolluri S, Bachinsky M, Cavus I. Adjunctive oral ziprasidone in patients with acute mania treated with lithium or divalproex, part 2: influence of protocol-specific eligibility criteria on signal detection. J Clin Psychiatry. 2012 Nov; 73(11):1420-5. PMID: 23218158.
    Citations: 3     Fields:    Translation:Humans
  25. Lombardo I, Sachs G, Kolluri S, Kremer C, Yang R. Two 6-week, randomized, double-blind, placebo-controlled studies of ziprasidone in outpatients with bipolar I depression: did baseline characteristics impact trial outcome? J Clin Psychopharmacol. 2012 Aug; 32(4):470-8. PMID: 22722504.
    Citations: 13     Fields:    Translation:Humans
  26. Sachs G, Winklbaur B, Jagsch R, Lasser I, Kryspin-Exner I, Frommann N, Wölwer W. Training of affect recognition (TAR) in schizophrenia--impact on functional outcome. Schizophr Res. 2012 Jul; 138(2-3):262-7. PMID: 22464728.
    Citations: 17     Fields:    Translation:Humans
  27. Sachs GS, Ice KS, Chappell PB, Schwartz JH, Gurtovaya O, Vanderburg DG, Kasuba B. Efficacy and safety of adjunctive oral ziprasidone for acute treatment of depression in patients with bipolar I disorder: a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry. 2011 Oct; 72(10):1413-22. PMID: 21672493.
    Citations: 20     Fields:    Translation:Humans
  28. Sylvia LG, Dupuy JM, Ostacher MJ, Cowperthwait CM, Hay AC, Sachs GS, Nierenberg AA, Perlis RH. Sleep disturbance in euthymic bipolar patients. J Psychopharmacol. 2012 Aug; 26(8):1108-12. PMID: 21965189.
    Citations: 21     Fields:    Translation:Humans
  29. Kemp DE, Karayal ON, Calabrese JR, Sachs GS, Pappadopulos E, Ice KS, Siu CO, Vieta E. Ziprasidone with adjunctive mood stabilizer in the maintenance treatment of bipolar I disorder: long-term changes in weight and metabolic profiles. Eur Neuropsychopharmacol. 2012 Feb; 22(2):123-31. PMID: 21798721.
    Citations: 7     Fields:    Translation:Humans
  30. Gruber J, Miklowitz DJ, Harvey AG, Frank E, Kupfer D, Thase ME, Sachs GS, Ketter TA. Sleep matters: sleep functioning and course of illness in bipolar disorder. J Affect Disord. 2011 Nov; 134(1-3):416-20. PMID: 21683450.
    Citations: 30     Fields:    Translation:Humans
  31. Bowden CL, Perlis RH, Thase ME, Ketter TA, Ostacher MM, Calabrese JR, Reilly-Harrington NA, Gonzalez JM, Singh V, Nierenberg AA, Sachs GS. Aims and results of the NIMH systematic treatment enhancement program for bipolar disorder (STEP-BD). CNS Neurosci Ther. 2012 Mar; 18(3):243-9. PMID: 22070541.
    Citations: 14     Fields:    Translation:Humans
  32. Sachs GS, Dupuy JM, Wittmann CW. The pharmacologic treatment of bipolar disorder. J Clin Psychiatry. 2011 May; 72(5):704-15. PMID: 21658351.
    Citations: 1     Fields:    Translation:HumansPHPublic Health
  33. Dias RS, Lafer B, Russo C, Del Debbio A, Nierenberg AA, Sachs GS, Joffe H. Longitudinal follow-up of bipolar disorder in women with premenstrual exacerbation: findings from STEP-BD. Am J Psychiatry. 2011 Apr; 168(4):386-94. PMID: 21324951.
    Citations: 12     Fields:    Translation:Humans
  34. Barnett JH, Huang J, Perlis RH, Young MM, Rosenbaum JF, Nierenberg AA, Sachs G, Nimgaonkar VL, Miklowitz DJ, Smoller JW. Personality and bipolar disorder: dissecting state and trait associations between mood and personality. Psychol Med. 2011 Aug; 41(8):1593-604. PMID: 21134316.
    Citations: 25     Fields:    Translation:Humans
  35. Deckersbach T, Nierenberg AA, Kessler R, Lund HG, Ametrano RM, Sachs G, Rauch SL, Dougherty D. RESEARCH: Cognitive rehabilitation for bipolar disorder: An open trial for employed patients with residual depressive symptoms. CNS Neurosci Ther. 2010 Oct; 16(5):298-307. PMID: 19895584.
    Citations: 45     Fields:    Translation:HumansCTClinical Trials
  36. Perlis RH, Ostacher MJ, Goldberg JF, Miklowitz DJ, Friedman E, Calabrese J, Thase ME, Sachs GS. Transition to mania during treatment of bipolar depression. Neuropsychopharmacology. 2010 Dec; 35(13):2545-52. PMID: 20827274.
    Citations: 13     Fields:    Translation:Humans
  37. Huang J, Perlis RH, Lee PH, Rush AJ, Fava M, Sachs GS, Lieberman J, Hamilton SP, Sullivan P, Sklar P, Purcell S, Smoller JW. Cross-disorder genomewide analysis of schizophrenia, bipolar disorder, and depression. Am J Psychiatry. 2010 Oct; 167(10):1254-63. PMID: 20713499.
    Citations: 73     Fields:    Translation:HumansCells
  38. Reilly-Harrington NA, DeBonis D, Leon AC, Sylvia L, Perlis R, Lewis D, Sachs GS. The interactive computer interview for mania. Bipolar Disord. 2010 Aug; 12(5):521-7. PMID: 20712753.
    Citations: 1     Fields:    Translation:Humans
  39. Sachs G, Winklbaur B, Jagsch R, Keefe RS. Validation of the German version of the brief assessment of cognition in Schizophrenia (BACS) - preliminary results. Eur Psychiatry. 2011 Mar; 26(2):74-7. PMID: 20427153.
    Citations: 6     Fields:    Translation:Humans
  40. Ghaemi SN, Ostacher MM, El-Mallakh RS, Borrelli D, Baldassano CF, Kelley ME, Filkowski MM, Hennen J, Sachs GS, Goodwin FK, Baldessarini RJ. Antidepressant discontinuation in bipolar depression: a Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) randomized clinical trial of long-term effectiveness and safety. J Clin Psychiatry. 2010 Apr; 71(4):372-80. PMID: 20409444.
    Citations: 29     Fields:    Translation:HumansPHPublic Health
  41. Perlis RH, Ostacher MJ, Miklowitz DJ, Hay A, Nierenberg AA, Thase ME, Sachs GS. Clinical features associated with poor pharmacologic adherence in bipolar disorder: results from the STEP-BD study. J Clin Psychiatry. 2010 Mar; 71(3):296-303. PMID: 20331931.
    Citations: 30     Fields:    Translation:Humans
  42. Perlis RH, Ostacher M, Fava M, Nierenberg AA, Sachs GS, Rosenbaum JF. Assuring that double-blind is blind. Am J Psychiatry. 2010 Mar; 167(3):250-2. PMID: 20194487.
    Citations: 14     Fields:    Translation:Humans
  43. Perlis RH, Ostacher MJ, Miklowitz DJ, Smoller JW, Dennehy EB, Cowperthwait C, Nierenberg AA, Thase ME, Sachs GS. Benzodiazepine use and risk of recurrence in bipolar disorder: a STEP-BD report. J Clin Psychiatry. 2010 Feb; 71(2):194-200. PMID: 20193647.
    Citations: 6     Fields:    Translation:HumansPHPublic Health
  44. Furtner J, Prayer D, Sachs G. [Functional MRI in schizophrenia. Diagnostics and therapy monitoring of cognitive deficits of schizophrenic patients by functional MRI]. Radiologe. 2010 Feb; 50(2):131-5. PMID: 20076939.
    Citations:    Fields:    Translation:Humans
  45. Casamassima F, Huang J, Fava M, Sachs GS, Smoller JW, Cassano GB, Lattanzi L, Fagerness J, Stange JP, Perlis RH. Phenotypic effects of a bipolar liability gene among individuals with major depressive disorder. . 2010 Jan 05; 153B(1):303-9. PMID: 19388002.
    Citations: 19     Translation:Humans
  46. Fan J, Ionita-Laza I, McQueen MB, Devlin B, Purcell S, Faraone SV, Allen MH, Bowden CL, Calabrese JR, Fossey MD, Friedman ES, Gyulai L, Hauser P, Ketter TB, Marangell LB, Miklowitz DJ, Nierenberg AA, Patel JK, Sachs GS, Thase ME, Molay FB, Escamilla MA, Nimgaonkar VL, Sklar P, Laird NM, Smoller JW. Linkage disequilibrium mapping of the chromosome 6q21-22.31 bipolar I disorder susceptibility locus. . 2010 Jan 05; 153B(1):29-37. PMID: 19308960.
    Citations: 7     Translation:HumansCells
  47. Ostacher MJ, Perlis RH, Nierenberg AA, Calabrese J, Stange JP, Salloum I, Weiss RD, Sachs GS. Impact of substance use disorders on recovery from episodes of depression in bipolar disorder patients: prospective data from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Am J Psychiatry. 2010 Mar; 167(3):289-97. PMID: 20008948.
    Citations: 26     Fields:    Translation:HumansPHPublic Health
  48. Kane JM, Barnes TR, Correll CU, Sachs G, Buckley P, Eudicone J, McQuade R, Tran QV, Pikalov A, Assunção-Talbott S. Evaluation of akathisia in patients with schizophrenia, schizoaffective disorder, or bipolar I disorder: a post hoc analysis of pooled data from short- and long-term aripiprazole trials. J Psychopharmacol. 2010 Jul; 24(7):1019-29. PMID: 20008446.
    Citations: 13     Fields:    Translation:Humans
  49. Perlis RH, Ostacher MJ, Uher R, Nierenberg AA, Casamassima F, Kansky C, Calabrese JR, Thase M, Sachs GS. Stability of symptoms across major depressive episodes in bipolar disorder. Bipolar Disord. 2009 Dec; 11(8):867-75. PMID: 19922555.
    Citations: 1     Fields:    Translation:Humans
  50. Mansour HA, Talkowski ME, Wood J, Chowdari KV, McClain L, Prasad K, Montrose D, Fagiolini A, Friedman ES, Allen MH, Bowden CL, Calabrese J, El-Mallakh RS, Escamilla M, Faraone SV, Fossey MD, Gyulai L, Loftis JM, Hauser P, Ketter TA, Marangell LB, Miklowitz DJ, Nierenberg AA, Patel J, Sachs GS, Sklar P, Smoller JW, Laird N, Keshavan M, Thase ME, Axelson D, Birmaher B, Lewis D, Monk T, Frank E, Kupfer DJ, Devlin B, Nimgaonkar VL. Association study of 21 circadian genes with bipolar I disorder, schizoaffective disorder, and schizophrenia. Bipolar Disord. 2009 Nov; 11(7):701-10. PMID: 19839995.
    Citations: 55     Fields:    Translation:Humans
  51. Ostacher MJ, Lebeau RT, Perlis RH, Nierenberg AA, Lund HG, Moshier SJ, Sachs GS, Simon NM. Cigarette smoking is associated with suicidality in bipolar disorder. Bipolar Disord. 2009 Nov; 11(7):766-71. PMID: 19840000.
    Citations: 18     Fields:    Translation:Humans
  52. Klein M, Gauggel S, Sachs G, Pohl W. Impact of chronic obstructive pulmonary disease (COPD) on attention functions. Respir Med. 2010 Jan; 104(1):52-60. PMID: 19748260.
    Citations: 15     Fields:    Translation:Humans
  53. Ng F, Mammen OK, Wilting I, Sachs GS, Ferrier IN, Cassidy F, Beaulieu S, Yatham LN, Berk M. The International Society for Bipolar Disorders (ISBD) consensus guidelines for the safety monitoring of bipolar disorder treatments. Bipolar Disord. 2009 Sep; 11(6):559-95. PMID: 19689501.
    Citations: 34     Fields:    Translation:Humans
  54. Tohen M, Frank E, Bowden CL, Colom F, Ghaemi SN, Yatham LN, Malhi GS, Calabrese JR, Nolen WA, Vieta E, Kapczinski F, Goodwin GM, Suppes T, Sachs GS, Chengappa KR, Grunze H, Mitchell PB, Kanba S, Berk M. The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders. Bipolar Disord. 2009 Aug; 11(5):453-73. PMID: 19624385.
    Citations: 71     Fields:    Translation:Humans
  55. Kogan JN, Bauer MS, Dennehy EB, Miklowitz DJ, Gonzalez JM, Thompson PM, Sachs GS. Increasing minority research participation through collaboration with community outpatient clinics: the STEP-BD Community Partners Experience. Clin Trials. 2009 Aug; 6(4):344-54. PMID: 19587069.
    Citations: 7     Fields:    Translation:Humans
  56. Perlis RH, Dennehy EB, Miklowitz DJ, Delbello MP, Ostacher M, Calabrese JR, Ametrano RM, Wisniewski SR, Bowden CL, Thase ME, Nierenberg AA, Sachs G. Retrospective age at onset of bipolar disorder and outcome during two-year follow-up: results from the STEP-BD study. Bipolar Disord. 2009 Jun; 11(4):391-400. PMID: 19500092.
    Citations: 77     Fields:    Translation:Humans
  57. Hlubocky FJ, Larson E, Ratain MJ, Sachs G, Daugherty CK. Cognitive function (CF) and prognostic information understanding in advanced cancer patients (ACP). J Clin Oncol. 2009 May 20; 27(15_suppl):9516. PMID: 27964487.
  58. Perlis RH, Smoller JW, Ferreira MA, McQuillin A, Bass N, Lawrence J, Sachs GS, Nimgaonkar V, Scolnick EM, Gurling H, Sklar P, Purcell S. A genomewide association study of response to lithium for prevention of recurrence in bipolar disorder. Am J Psychiatry. 2009 Jun; 166(6):718-25. PMID: 19448189.
    Citations: 51     Fields:    Translation:HumansCellsPHPublic HealthCTClinical Trials
  59. Goldberg JF, Brooks JO, Kurita K, Hoblyn JC, Ghaemi SN, Perlis RH, Miklowitz DJ, Ketter TA, Sachs GS, Thase ME. Depressive illness burden associated with complex polypharmacy in patients with bipolar disorder: findings from the STEP-BD. J Clin Psychiatry. 2009 Feb; 70(2):155-62. PMID: 19210946.
    Citations: 51     Fields:    Translation:Humans
  60. Kaufman RE, Ostacher MJ, Marks EH, Simon NM, Sachs GS, Jensen JE, Renshaw PF, Pollack MH. Brain GABA levels in patients with bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2009 Apr 30; 33(3):427-34. PMID: 19171176.
    Citations: 19     Fields:    Translation:Humans
  61. Goldberg JF, Perlis RH, Bowden CL, Thase ME, Miklowitz DJ, Marangell LB, Calabrese JR, Nierenberg AA, Sachs GS. Manic symptoms during depressive episodes in 1,380 patients with bipolar disorder: findings from the STEP-BD. Am J Psychiatry. 2009 Feb; 166(2):173-81. PMID: 19122008.
    Citations: 68     Fields:    Translation:Humans
  62. Busch AB, Frank RG, Sachs G, Normand SL. Bipolar-I patient characteristics associated with differences in antimanic medication prescribing. Psychopharmacol Bull. 2009; 42(1):35-49. PMID: 19204650.
    Citations: 5     Fields:    Translation:Humans
  63. Iosifescu DV, Moore CM, Deckersbach T, Tilley CA, Ostacher MJ, Sachs GS, Nierenberg AA. Galantamine-ER for cognitive dysfunction in bipolar disorder and correlation with hippocampal neuronal viability: a proof-of-concept study. CNS Neurosci Ther. 2009; 15(4):309-19. PMID: 19889129.
    Citations: 11     Fields:    Translation:HumansCTClinical Trials
  64. Tohen M, Sutton VK, Calabrese JR, Sachs GS, Bowden CL. Maintenance of response following stabilization of mixed index episodes with olanzapine monotherapy in a randomized, double-blind, placebo-controlled study of bipolar 1 disorder. J Affect Disord. 2009 Jul; 116(1-2):43-50. PMID: 19054570.
    Citations: 8     Fields:    Translation:HumansPHPublic Health
  65. Deckersbach T, Rauch SL, Buhlmann U, Ostacher MJ, Beucke JC, Nierenberg AA, Sachs G, Dougherty DD. An fMRI investigation of working memory and sadness in females with bipolar disorder: a brief report. Bipolar Disord. 2008 Dec; 10(8):928-42. PMID: 19594508.
    Citations: 16     Fields:    Translation:Humans
  66. Ferreira MA, O'Donovan MC, Meng YA, Jones IR, Ruderfer DM, Jones L, Fan J, Kirov G, Perlis RH, Green EK, Smoller JW, Grozeva D, Stone J, Nikolov I, Chambert K, Hamshere ML, Nimgaonkar VL, Moskvina V, Thase ME, Caesar S, Sachs GS, Franklin J, Gordon-Smith K, Ardlie KG, Gabriel SB, Fraser C, Blumenstiel B, Defelice M, Breen G, Gill M, Morris DW, Elkin A, Muir WJ, McGhee KA, Williamson R, MacIntyre DJ, MacLean AW, St CD, Robinson M, Van Beck M, Pereira AC, Kandaswamy R, McQuillin A, Collier DA, Bass NJ, Young AH, Lawrence J, Ferrier IN, Anjorin A, Farmer A, Curtis D, Scolnick EM, McGuffin P, Daly MJ, Corvin AP, Holmans PA, Blackwood DH, Gurling HM, Owen MJ, Purcell SM, Sklar P, Craddock N. Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder. Nat Genet. 2008 Sep; 40(9):1056-8. PMID: